{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:42:44Z","timestamp":1790710964572,"version":"4.1.0"},"reference-count":87,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:00:00Z","timestamp":1607990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:00:00Z","timestamp":1607990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T00:00:00Z","timestamp":1606694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.csbj.2020.11.056","type":"journal-article","created":{"date-parts":[[2020,12,6]],"date-time":"2020-12-06T09:46:23Z","timestamp":1607247983000},"page":"1-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses"],"prefix":"10.34133","volume":"19","author":[{"given":"Guobing","family":"Li","sequence":"first","affiliation":[{"name":"Center of Basic Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China"},{"name":"Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Ruan","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China"},{"name":"The First Clinical College of Wuhan University, Wuhan, Hubei 430060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Zhao","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[{"name":"Stem Cell Program, Division of Hematology\/Oncology, Boston Children's Hospital, Boston, MA 02115, USA"},{"name":"Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Dou","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengbiao","family":"Mao","sequence":"additional","affiliation":[{"name":"Center of Basic Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2020,12,15]]},"reference":[{"key":"e_1_3_5_2_2","unstructured":"Health. C-TGPNIo. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines; 2020."},{"key":"e_1_3_5_3_2","doi-asserted-by":"crossref","unstructured":"Diao B Wang C Tan Y Chen X Liu Y et al. Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19). Front Immunol. 2020;11:827.","DOI":"10.3389\/fimmu.2020.00827"},{"key":"e_1_3_5_4_2","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"1","author":"Gordon D.E.","year":"2020","unstructured":"Gordon D.E., Jang G.M., Bouhaddou M., Xu J., Obernier K. et al: A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 2020; 1\u201313.","journal-title":"Nature"},{"key":"e_1_3_5_5_2","article-title":"Compassionate Use of Remdesivir for Patients with Severe Covid-19","author":"Grein J.","year":"2020","unstructured":"Grein J., Ohmagari N., Shin D., Diaz G., Asperges E. et al: Compassionate Use of Remdesivir for Patients with Severe Covid-19. N Engl J Med 2020; .","journal-title":"N Engl J Med"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31022-9"},{"key":"e_1_3_5_7_2","doi-asserted-by":"crossref","unstructured":"Teng H Wei W Li Q Xue M Shi X et al. Prevalence and architecture of posttranscriptionally impaired synonymous mutations in 8 320 genomes across 22 cancer types. Nucleic Acids Res. 2020;48(3):1192\u2013205.","DOI":"10.1093\/nar\/gkaa019"},{"key":"e_1_3_5_8_2","doi-asserted-by":"crossref","unstructured":"Wang H Wang T Zhao X Wu H You M et al. AI-Driver: an ensemble method for identifying driver mutations in personal cancer genomes. NAR Genomics Bioinformatics. 2020;2(4).","DOI":"10.1093\/nargab\/lqaa084"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1308"},{"key":"e_1_3_5_10_2","doi-asserted-by":"crossref","unstructured":"Liu S Zheng Q Wang Z. Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus. Bioinformatics; 2020.","DOI":"10.1093\/bioinformatics\/btaa224"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb8925"},{"key":"e_1_3_5_12_2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093330","article-title":"Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity","volume":"21","author":"Picchianti Diamanti A.","year":"2020","unstructured":"Picchianti Diamanti A., Rosado M.M., Pioli C., Sesti G. and Lagana B.: Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity. Int J Mol Sci 2020; 21.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_5_13_2","doi-asserted-by":"crossref","unstructured":"Biggest COVID-19 trial tests repurposed drugs first. Nat Biotechnol. 2020;38(5):510.","DOI":"10.1038\/s41587-020-0528-x"},{"key":"e_1_3_5_14_2","doi-asserted-by":"crossref","first-page":"D92","DOI":"10.1093\/nar\/gkx918","article-title":"EpiDenovo: a platform for linking regulatory de novo mutations to developmental epigenetics and diseases","volume":"46","author":"Mao F.","year":"2018","unstructured":"Mao F., Liu Q., Zhao X., Yang H., Guo S. et al: EpiDenovo: a platform for linking regulatory de novo mutations to developmental epigenetics and diseases. Nucleic Acids Res 2018; 46: D92.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0201-4"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp352"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8"},{"key":"e_1_3_5_18_2","article-title":"OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers","author":"Wang T.","year":"2020","unstructured":"Wang T., Ruan S., Zhao X., Shi X., Teng H. et al: OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers. Nucleic Acids Res 2020; .","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky900"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1139"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.08.018"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz401"},{"key":"e_1_3_5_24_2","first-page":"1","article-title":"Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd","volume":"7","author":"Wang Z.","year":"2016","unstructured":"Wang Z., Monteiro C.D., Jagodnik K.M., Fernandez N.F., Gundersen G.W. et al: Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd. Nat Commun 2016; 7: 1.","journal-title":"Nat Commun"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.04.026"},{"key":"e_1_3_5_26_2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/annrheumdis-2020-217460","article-title":"Role of immunosuppressive therapy in rheumatic diseases concurrent with COVID-19","volume":"79","author":"Lu C.","year":"2020","unstructured":"Lu C., Li S. and Liu Y.: Role of immunosuppressive therapy in rheumatic diseases concurrent with COVID-19. Ann Rheum Dis 2020; 79: 737.","journal-title":"Ann Rheum Dis"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30628-0"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1747363"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.04.001"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-018-0304-1"},{"key":"e_1_3_5_31_2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3389\/fonc.2018.00374","article-title":"Prognostic Genes of Breast Cancer Identified by Gene Co-expression Network Analysis","volume":"8","author":"Tang J.","year":"2018","unstructured":"Tang J., Kong D., Cui Q., Wang K., Zhang D. et al: Prognostic Genes of Breast Cancer Identified by Gene Co-expression Network Analysis. Front Oncol 2018; 8: 374.","journal-title":"Front Oncol"},{"key":"e_1_3_5_32_2","article-title":"A Dynamic Immune Response Shapes COVID-19 Progression","author":"Ong E.Z.","year":"2020","unstructured":"Ong E.Z., Chan Y.F.Z., Leong W.Y., Lee N.M.Y., Kalimuddin S. et al: A Dynamic Immune Response Shapes COVID-19 Progression. Cell Host Microbe 2020; .","journal-title":"Cell Host Microbe"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.171256"},{"key":"e_1_3_5_34_2","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.4049\/jimmunol.160.8.4057","article-title":"Human polymorphonuclear leukocytes adhere to complement factor H through an interaction that involves alphaMbeta2 (CD11b\/CD18)","volume":"160","author":"DiScipio R.G.","year":"1998","unstructured":"DiScipio R.G., Daffern P.J., Schraufstatter I.U. and Sriramarao P.: Human polymorphonuclear leukocytes adhere to complement factor H through an interaction that involves alphaMbeta2 (CD11b\/CD18). J Immunol 1998; 160: 4057.","journal-title":"J Immunol"},{"key":"e_1_3_5_35_2","doi-asserted-by":"crossref","first-page":"912","DOI":"10.4049\/jimmunol.0901702","article-title":"Factor H and factor H-related protein 1 bind to human neutrophils via complement receptor 3, mediate attachment to Candida albicans, and enhance neutrophil antimicrobial activity","volume":"184","author":"Losse J.","year":"2010","unstructured":"Losse J., Zipfel P.F. and Jozsi M.: Factor H and factor H-related protein 1 bind to human neutrophils via complement receptor 3, mediate attachment to Candida albicans, and enhance neutrophil antimicrobial activity. J Immunol 2010; 184: 912.","journal-title":"J Immunol"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20091021"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M208602200"},{"key":"e_1_3_5_38_2","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.3389\/fimmu.2018.02235","article-title":"CD22: a regulator of innate and adaptive B cell responses and autoimmunity","volume":"9","author":"Clark E.A.","year":"2018","unstructured":"Clark E.A. and Giltiay N.V.: CD22: a regulator of innate and adaptive B cell responses and autoimmunity. Front Immunol 2018; 9: 2235.","journal-title":"Front Immunol"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2016.02.001"},{"key":"e_1_3_5_40_2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fncel.2015.00284","article-title":"Modulation of TLR3\/TLR4 inflammatory signaling by the GABAB receptor agonist baclofen in glia and immune cells: relevance to therapeutic effects in multiple sclerosis","volume":"9","author":"Crowley T.","year":"2015","unstructured":"Crowley T., Fitzpatrick J.-M., Kuijper T., Cryan J.F., O\u2019Toole O. et al: Modulation of TLR3\/TLR4 inflammatory signaling by the GABAB receptor agonist baclofen in glia and immune cells: relevance to therapeutic effects in multiple sclerosis. Front Cell Neurosci 2015; 9: 284.","journal-title":"Front Cell Neurosci"},{"key":"e_1_3_5_41_2","article-title":"Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia","author":"Guilpain P.","year":"2020","unstructured":"Guilpain P., Le Bihan C., Foulongne V., Taourel P., Pansu N. et al: Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia. Ann Rheum Dis 2020; .","journal-title":"Ann Rheum Dis"},{"key":"e_1_3_5_42_2","article-title":"Triple combination of interferon beta-1b, lopinavir\u2013ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial","author":"Hung I.-F.-N.","year":"2020","unstructured":"Hung I.-F.-N., Lung K.-C., Tso E.-Y.-K., Liu R., Chung T.-W.-H. et al: Triple combination of interferon beta-1b, lopinavir\u2013ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. The Lancet 2020; .","journal-title":"The Lancet"},{"key":"e_1_3_5_43_2","article-title":"Coronavirus disease 2019 and transplantation: The combination of lopinavir\/ritonavir and hydroxychloroquine is responsible for excessive tacrolimus trough level and unfavorable outcome","author":"Xia T.","year":"2020","unstructured":"Xia T. and Wang Y.: Coronavirus disease 2019 and transplantation: The combination of lopinavir\/ritonavir and hydroxychloroquine is responsible for excessive tacrolimus trough level and unfavorable outcome. Am J Transplant 2020; .","journal-title":"Am J Transplant"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001282"},{"key":"e_1_3_5_45_2","doi-asserted-by":"crossref","unstructured":"Yazdany J Kim AH. Use of hydroxychloroquine and chloroquine during the COVID-19 pandemic: what every clinician should know; 2020.","DOI":"10.7326\/M20-1334"},{"key":"e_1_3_5_46_2","doi-asserted-by":"crossref","unstructured":"Ferner RE Aronson JK. Chloroquine and hydroxychloroquine in covid-19; 2020.","DOI":"10.1136\/bmj.m1432"},{"key":"e_1_3_5_47_2","article-title":"COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options","author":"Guzik T.J.","year":"2020","unstructured":"Guzik T.J., Mohiddin S.A., Dimarco A., Patel V., Savvatis K. et al: COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res 2020; .","journal-title":"Cardiovasc Res"},{"key":"e_1_3_5_48_2","article-title":"Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19","author":"Magagnoli J.","year":"2020","unstructured":"Magagnoli J., Narendran S., Pereira F., Cummings T., Hardin J.W. et al: Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19. medrxiv 2020; .","journal-title":"medrxiv"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2020.06.001"},{"key":"e_1_3_5_50_2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cytogfr.2020.06.014","article-title":"A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization","volume":"54","author":"Johnson B.S.","year":"2020","unstructured":"Johnson B.S. and Laloraya M.: A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization. Cytokine Growth Factor Rev 2020; 54: 32.","journal-title":"Cytokine Growth Factor Rev"},{"key":"e_1_3_5_51_2","first-page":"1","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","author":"Zheng M.","year":"2020","unstructured":"Zheng M., Gao Y., Wang G., Song G., Liu S. et al: Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol 2020; : 1.","journal-title":"Cell Mol Immunol"},{"key":"e_1_3_5_52_2","article-title":"Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient","volume":"1","author":"Yao X.-H.","year":"2020","unstructured":"Yao X.-H., He Z.-C., Li T.-Y., Zhang H.-R., Wang Y. et al: Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient. Cell Res 2020; 1\u20133.","journal-title":"Cell Res"},{"key":"e_1_3_5_53_2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41577-020-0312-7","article-title":"COVID-19: risk for cytokine targeting in chronic inflammatory diseases?","volume":"20","author":"Schett G.","year":"2020","unstructured":"Schett G., Sticherling M. and Neurath M.F.: COVID-19: risk for cytokine targeting in chronic inflammatory diseases?. Nat Rev Immunol 2020; 20: 271.","journal-title":"Nat Rev Immunol"},{"key":"e_1_3_5_54_2","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19","author":"Ackermann M.","year":"2020","unstructured":"Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T. et al: Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med 2020; .","journal-title":"N Engl J Med"},{"key":"e_1_3_5_55_2","article-title":"Nervous system involvement after infection with COVID-19 and other coronaviruses","author":"Wu Y.","year":"2020","unstructured":"Wu Y., Xu X., Chen Z., Duan J., Hashimoto K. et al: Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 2020; .","journal-title":"Brain Behav Immun"},{"key":"e_1_3_5_56_2","doi-asserted-by":"crossref","unstructured":"Mao L Jin H Wang M Hu Y Chen S et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan China. JAMA Neurol; 2020.","DOI":"10.1001\/jamaneurol.2020.1127"},{"key":"e_1_3_5_57_2","article-title":"Does COVID-19 affect male fertility?","volume":"1","author":"Abobaker A.","year":"2020","unstructured":"Abobaker A. and Raba A.A.: Does COVID-19 affect male fertility?. World J Urol 2020; 1\u20132.","journal-title":"World J Urol"},{"key":"e_1_3_5_58_2","article-title":"Effect of SARS-CoV-2 infection upon male gonadal function: A single center-based study","author":"Ma L.","year":"2020","unstructured":"Ma L., Xie W., Li D., Shi L., Mao Y. et al: Effect of SARS-CoV-2 infection upon male gonadal function: A single center-based study. medRxiv 2020; .","journal-title":"medRxiv"},{"key":"e_1_3_5_59_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00827"},{"key":"e_1_3_5_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2016.01.007"},{"key":"e_1_3_5_61_2","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(20)30858-8","article-title":"Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed","volume":"395","author":"Feldmann M.","year":"2020","unstructured":"Feldmann M., Maini R.N., Woody J.N., Holgate S.T., Winter G. et al: Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. The Lancet 2020; 395: 1407.","journal-title":"The Lancet"},{"key":"e_1_3_5_62_2","article-title":"Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept","author":"Duret P.M.","year":"2020","unstructured":"Duret P.M., Sebbag E., Mallick A., Gravier S., Spielmann L. et al: Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. Ann Rheum Dis 2020; .","journal-title":"Ann Rheum Dis"},{"key":"e_1_3_5_63_2","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","author":"Xu X.","year":"2020","unstructured":"Xu X., Han M., Li T., Sun W., Wang D. et al: Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A 2020; .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_5_64_2","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.3390\/ijms21093330","article-title":"Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity","volume":"21","author":"Picchianti Diamanti A.","year":"2020","unstructured":"Picchianti Diamanti A., Rosado M.M., Pioli C., Sesti G. and Lagan\u00e0 B.: Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity. Int J Mol Sci 2020; 21: 3330.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_5_65_2","unstructured":"Tepasse P-R Hafezi W Lutz M K\u00fchn J Wilms C et al. Persisting SARS-CoV-2 viremia after rituximab therapy: Two cases with fatal outcome and a review of literature. British Journal of Haematology. n\/a(n\/a)."},{"key":"e_1_3_5_66_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001282"},{"key":"e_1_3_5_67_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074082","article-title":"Host targeted activity of pyrazinamide in Mycobacterium tuberculosis infection","volume":"8","author":"Manca C.","year":"2013","unstructured":"Manca C., Koo M.-S., Peixoto B., Fallows D., Kaplan G. et al: Host targeted activity of pyrazinamide in Mycobacterium tuberculosis infection. PLoS ONE 2013; 8.","journal-title":"PLoS ONE"},{"key":"e_1_3_5_68_2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/imm.12902","article-title":"Immune modulatory effects of statins","volume":"154","author":"Zeiser R.","year":"2018","unstructured":"Zeiser R.: Immune modulatory effects of statins. Immunology 2018; 154: 69.","journal-title":"Immunology"},{"key":"e_1_3_5_69_2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/872370"},{"key":"e_1_3_5_70_2","doi-asserted-by":"crossref","unstructured":"Yuan S. Statins May Decrease the Fatality Rate of Middle East Respiratory Syndrome Infection. mBio. 2015;6(4):e01120.","DOI":"10.1128\/mBio.01120-15"},{"key":"e_1_3_5_71_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104803","article-title":"Statins in coronavirus outbreak: It's time for experimental and clinical studies","volume":"156","author":"Bifulco M.","year":"2020","unstructured":"Bifulco M. and Gazzerro P.: Statins in coronavirus outbreak: It's time for experimental and clinical studies. Pharmacol Res 2020; 156: 104803.","journal-title":"Pharmacol Res"},{"key":"e_1_3_5_72_2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.5114\/aoms.2020.94655","article-title":"Statins and the COVID-19 main protease: in silico evidence on direct interaction","volume":"16","author":"Reiner Z.","year":"2020","unstructured":"Reiner Z., Hatamipour M., Banach M., Pirro M., Al-Rasadi K. et al: Statins and the COVID-19 main protease: in silico evidence on direct interaction. Arch Med Sci 2020; 16: 490.","journal-title":"Arch Med Sci"},{"key":"e_1_3_5_73_2","unstructured":"China NHCotPsRo. National Health Committee of the People\u2019s Republic of China (2020) Guideline for Diagnosis and Treatment of Novel Coronavirus Pneumonia (Trial Version Fourth); 2020."},{"key":"e_1_3_5_74_2","article-title":"Role of immunosuppressive therapy in rheumatic diseases concurrent with covid-19","author":"Lu C.","year":"2020","unstructured":"Lu C., Li S. and Liu Y.: Role of immunosuppressive therapy in rheumatic diseases concurrent with covid-19. Ann Rheum Dis 2020; .","journal-title":"Ann Rheum Dis"},{"key":"e_1_3_5_75_2","article-title":"Early Short Course Corticosteroids in Hospitalized Patients with COVID-19","author":"Fadel R.","year":"2020","unstructured":"Fadel R., Morrison A.R., Vahia A., Smith Z.R., Chaudhry Z. et al: Early Short Course Corticosteroids in Hospitalized Patients with COVID-19. Clin Infect Dis 2020; .","journal-title":"Clin Infect Dis"},{"key":"e_1_3_5_76_2","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(20)30149-2","article-title":"Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection","author":"Isidori A.M.","year":"2020","unstructured":"Isidori A.M., Pofi R., Hasenmajer V., Lenzi A. and Pivonello R.: Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection. Lancet Diabetes Endocrinol 2020; .","journal-title":"Lancet Diabetes Endocrinol"},{"key":"e_1_3_5_77_2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jchromb.2008.04.016","article-title":"Separation of chlorogenic acid from honeysuckle crude extracts by macroporous resins","volume":"867","author":"Zhang B.","year":"2008","unstructured":"Zhang B., Yang R., Zhao Y. and Liu C.Z.: Separation of chlorogenic acid from honeysuckle crude extracts by macroporous resins. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 867: 253.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"e_1_3_5_78_2","article-title":"Bao L-d. Exploring the Active Compounds of Traditional Mongolian Medicine in Intervention of Novel Coronavirus (COVID-19) Based on Molecular Docking Method","volume":"104016","author":"Yu J.-w.","year":"2020","unstructured":"Yu J.-w. and Wang L.: Bao L-d. Exploring the Active Compounds of Traditional Mongolian Medicine in Intervention of Novel Coronavirus (COVID-19) Based on Molecular Docking Method. J Funct Foods 2020; 104016.","journal-title":"J Funct Foods"},{"key":"e_1_3_5_79_2","doi-asserted-by":"crossref","unstructured":"Polansky H Lori G. Coronavirus disease 2019 (COVID-19): first indication of efficacy of Gene-Eden-VIR\/Novirin in SARS-CoV-2 infection. Int J Antimicrob Agents. 2020:105971.","DOI":"10.1016\/j.ijantimicag.2020.105971"},{"key":"e_1_3_5_80_2","unstructured":"Dandapat J Jena A Kanungo N Nayak V Chainy G. Catechin and Curcumin interact with corona (2019-nCoV\/SARS-CoV2) viral S protein and ACE2 of human cell membrane: insights from Computational study and implication for intervention; 2020."},{"key":"e_1_3_5_81_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057285","article-title":"Curcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndrome","volume":"8","author":"Avasarala S.","year":"2013","unstructured":"Avasarala S., Zhang F., Liu G., Wang R., London S.D. et al: Curcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndrome. PLoS ONE 2013; 8.","journal-title":"PLoS ONE"},{"key":"e_1_3_5_82_2","doi-asserted-by":"crossref","DOI":"10.2217\/fvl-2020-0079","article-title":"Virtual screening of immunomodulatory medicinal compounds as promising anti-SARS-COV-2 inhibitors","author":"Salman S.","year":"2020","unstructured":"Salman S., Shah F.H., Idrees J., Idrees F., Velagala S. et al: Virtual screening of immunomodulatory medicinal compounds as promising anti-SARS-COV-2 inhibitors. Future Virol 2020; .","journal-title":"Future Virol"},{"key":"e_1_3_5_83_2","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.3390\/ijms19061812","article-title":"Anti-inflammatory effects of resveratrol: Mechanistic insights","volume":"19","author":"de S\u00e1 Coutinho D","year":"2018","unstructured":"de S\u00e1 Coutinho D, Pacheco M.T., Frozza R.L. and Bernardi A.: Anti-inflammatory effects of resveratrol: Mechanistic insights. Int J Mol Sci 2018; 19: 1812.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_5_84_2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00011-003-1182-8","article-title":"Genistein as an anti-inflammatory agent","volume":"52","author":"Verdrengh M.","year":"2003","unstructured":"Verdrengh M., Jonsson I., Holmdahl R. and Tarkowski A.: Genistein as an anti-inflammatory agent. Inflamm Res 2003; 52: 341.","journal-title":"Inflamm Res"},{"key":"e_1_3_5_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.04.013"},{"key":"e_1_3_5_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.11.008"},{"key":"e_1_3_5_87_2","doi-asserted-by":"publisher","DOI":"10.1042\/BST20180169"},{"key":"e_1_3_5_88_2","doi-asserted-by":"crossref","DOI":"10.3390\/nu12041181","article-title":"Optimal Nutritional Status for a Well-Functioning Immune System Is an Important Factor to Protect against Viral Infections","volume":"12","author":"Calder P.C.","year":"2020","unstructured":"Calder P.C., Carr A.C., Gombart A.F. and Eggersdorfer M.: Optimal Nutritional Status for a Well-Functioning Immune System Is an Important Factor to Protect against Viral Infections. Nutrients 2020; 12.","journal-title":"Nutrients"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037020305237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037020305237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2020.11.056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T12:43:13Z","timestamp":1779021793000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2020.11.056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,15]]},"references-count":87,"alternative-id":["10.1016\/j.csbj.2020.11.056"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2020.11.056","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,15]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2020.11.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}